Peer-influenced content. Sources you trust. No registration required. This is HCN.

Pharmacy Practice NewsNew Iron Deficiency Guideline Reshapes Oral Dosing and Infusion Protocols

Guideline Update

Consensus recommendations address persistent variation in oral dosing, IV infusion protocols, pregnancy management, reaction classification, and follow-up after iron treatment.


Clinical Considerations

  • Oral iron more than once daily increases gastrointestinal effects without meaningfully improving absorption.
  • Guidance favors total-dose IV infusion and discourages routine test doses or premedication.
  • Pregnancy recommendations distinguish first-trimester oral therapy from later-trimester IV treatment.
  • Reassessment should occur no sooner than four weeks after IV administration.

Practice Applications

  • Review oral dosing frequency and elemental iron content.
  • Verify the implicated formulation before accepting an iron-allergy label.
  • Assess treatment tolerance, access, cost, and pregnancy stage.
  • Establish laboratory follow-up and evaluate the deficiency’s underlying cause.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form